+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
From
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Lymphocytic Leukemia- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Lymphocytic Leukemia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 210 Pages
  • Global
From
Immunology - Global Strategic Business Report - Product Thumbnail Image

Immunology - Global Strategic Business Report

  • Report
  • September 2025
  • 374 Pages
  • Global
From
Ebola Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Drugs and Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 485 Pages
  • Global
From
From
From
From
From
From
Stem Cells Market - Global Forecast 2025-2030 - Product Thumbnail Image

Stem Cells Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
Loading Indicator